# TYRUKO

NDC: 61314-543
Generic name: natalizumab-sztn
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20251117

FDA application: BLA761322

## Active ingredients

- NATALIZUMAB: 300 mg/15mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61314-543"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61314-543
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef653c36-dd4b-4e71-9d2d-40b8fea24b67